HEAL together with representatives from the medical, scientific, and civil society sectors, is calling on policymakers in Poland to develop a national action plan to reduce the health impacts of harmful chemicals and to support the revision of EU regulations. The appeal was presented on 10 June in Warsaw during the International Conference Preventing Disease by Reducing Exposure to Harmful Chemicals, held under the patronage of the Polish Presidency of the Council of the EU, the Polish Minister of Health, and the President of the Polish Supreme Medical Council.
The governments of the European Union are in the process of deciding whether to relicense chlorpyrifos – a pesticide widely used across Europe that has serious negative effects on the health of our children. What can we learn from the last time this pesticide was approved on the European markets?
The Health and Environment Alliance (HEAL) is organising a new series of webinars dedicated to the health and environmental impacts of chlorpyrifos, a pesticide widely used across Europe.
In the third and final webinar of the series, we invited Dr. Axel Mie (Karolinska Institutet, Stockholm) and Dr. Christina Rudén (Stockholm University) to present their review of the two main industry-funded studies on developmental neurotoxicity of chlorpyrifos and chlorpyrifos-methyl. These industry-funded studies have played a central role in the previous market approval of chlorpyrifos in Europe.
Their review rebuts the conclusions of the industry studies on the absence of neurodevelopmental effects of both substances, identifying many failures, shortcomings and inadequate interpretation of raw data. It also uses this case study to discuss some aspects of the current pesticide approval procedures and possible health-protective ways forward.
Webinar #3: Lessons learned from the approval of chlorpyrifos
Wednesday 12 June, 17:00 – 18:00 CET
Registration: https://ivonneleenen.typeform.com/to/klJhqu
Related Posts
